Clinical Trial Update: ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ELAPR002f Injectable Gel for atrophic acne scars is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ELAPR002f Injectable Gel

Snippet

Sponsor: AbbVie | Conditions: Atrophic Acne Scars | Phase 3 | Status: ACTIVE_NOT_RECRUITING